|
CME
| CME Credit, Disclaimer, Disclosure,
Meeting Objectives |
|
Target Audience: The target
audience will be orthopaedic surgeons, residents, fellows, and physicians
with an interest in orthopaedic treatment. Athletic trainers, physician
assistants, and clinic administrators/technical staff may also be
interested in the program.
Educational Method: Lecture
presentations, case studies, and hands-on workshops.
CME Accreditation and Credit Designation:
Texas Orthopaedic Association is accredited by the Texas
Medical Association to provide continuing medical education for
physicians. The Texas Orthopaedic Association designates AMA PRA Category
1 Credits for the following educational activities:
-
Thursday, April 23rd – Coding
Course – 8 AMA PRA Category 1 Credits
-
Friday, April 24th & Saturday,
April 25th – 16 AMA PRA Category 1 Credits
Physicians should only claim credit
commensurate with the extent of their participation in the activity.
Objectives: Upon completion of
this activity, participants will be able to obtain a comprehensive
perspective on the broad range of orthopaedic knowledge and surgical
practice, increase knowledge in the fundamentals of orthopaedic surgery in
basic and clinical science and all orthopaedic specialty areas, implement
more effective strategies for the prevention of musculoskeletal disease,
and provide opportunity to strengthen professional relationships. The
learning experience in this activity will promote education in orthopaedic
care, support a forum for discussion of current issues in orthopaedics,
provide instructions on procedures related to patient management, patient
health, physician performance and outcomes, provide the opportunity for a
surgical skills learning experience, provide education in advocacy issues
related to orthopaedics, promote patient safety and provide an opportunity
to discuss and debate in a case based learning environment. As a result
of participating in the activity, the learner will practice
evidence-based, informed orthopaedic care, demonstrate the application of
current techniques, procedures and research, apply knowledge to guide
clinical decisions, become more involved in advocacy issues related to
orthopaedics and learn about the latest technology and equipment for use
in patient care.
Disclaimer:
The material presented at the Annual Meeting has been made available by
the Texas Orthopaedic Association for educational purposes only. This
material is not intended to represent the only, nor necessarily best,
method or procedure appropriate for the medical situations discussed, but
rather is intended to present an approach, view, statement or opinion of
the faculty which may be helpful to others who face similar situations.
The TOA disclaims any and all liability for injury or other damages
resulting to any individuals attending a session for all claims, which may
arise out of the use of the techniques demonstrated therein by such
individuals, whether these claims shall be asserted by a physician or any
other person. No reproductions of any kind, including still photography,
audiotapes and videotapes, may be made of the presentation at the TOA
Annual Meeting. The Association reserves all of its rights to such
material, and commercial reproduction is specifically prohibited.
Disclosure:
Each participant in the Annual Meeting has been asked to disclose if he or
she has received something of value of a commercial company or
institution, which relates directly or indirectly to the subject of their
presentation. The TOA has identified the options to disclose as follows:
research or institutional support has been received; miscellaneous
non-income support (e.g. equipment or services); royalties; stock or stock
options; or consultant or employee and disclosed nothing of value
received. An indication of the participant’s
disclosure appears after his or her name as does the commercial company or
institution that provided the support. The TOA does not view the
existence of these disclosed interests or commitments as necessarily
implying bias or decreasing the value of the author’s participation at the
meeting.
FDA Statement: Some drugs or
medical devices demonstrated at the Annual Meeting have not been cleared
by the FDA or have been cleared by the FDA for specific purposes only.
The FDA has stated that it is the responsibility of the physician to
determine the FDA clearance status of each drug or medical devices he or
she wished to use in clinical practice.
TOA
policy provides that “off label” use of a drug or medical device may be
described in the TOA’s CME activities so long as the “off label” use of
the drug or medical device is also specifically disclosed (i.e. it must be
disclosed that the FDA has not cleared the drug or device for the
described purpose). Any drug or medical device is being used “off label”
if the described use is not set forth on the product’s approval label. |